ISSN: 2536-7064
Model: Open Access/Peer Reviewed
DOI: 10.31248/JBBD
Start Year: 2016
Email: jbbd@integrityresjournals.org
https://doi.org/10.31248/JBBD2017.060 | Article Number: 75E08EE63 | Vol.3 (1) - February 2018
Received Date: 20 December 2017 | Accepted Date: 22 January 2018 | Published Date: 28 February 2018
Authors: Mohammed Kachallah , Dalhatu Yusuf Bolus and Abdulrasheed Abdu
Keywords: Escherichia coli, uropathogenic, antimicrobial susceptibility, urinary tract infection, multi-drug resistance.
Escherichia coli (E. coli) has been identified as the most common uropathogenic bacterial pathogen with increasing resistance to antibiotics. Aetiology of urinary tract infections (UTI) and their antibiotic sensitivity patterns vary from time to time and across different areas. In Nigeria, studies on the prevalence and antimicrobial susceptibility patterns of clinical isolates from urinary tract infections are inadequate. Employing standardised microbiological methods, this study assessed the prevalence and antimicrobial susceptibility patterns of E. coli isolates from UTI in University of Maiduguri Teaching Hospital (a tertiary health care institution) in North Eastern, Nigeria. Uropathogenic E. coli (UPEC) accounted for 150 (62.50%) of 240 urine isolates. Lowest susceptibility was for Ampicillin 54 (36.0%), Ciprofloxacin 69 (46.0%) and Norfloxacin 72 (48.0%). More than 50% were susceptible to Levofloxacin and Streptomycin 71 (54.0%) each, Cefuroxime and Co-trimoxazole 78 (52.0%) each, while highest susceptibility was for Nitrofurantoin 117 (78.0%), Chloramphenicol 105 (70.0%) and Gentamicin 96 (64.0%). The isolates were commonly resistant to 9 (24.24%) of the ten (MARI of 0.9) classes of antimicrobial agents used in this study and all the isolates were multidrug-resistant. There is a need for proper surveillance and development of hospital specific antibiograms to inform appropriate empiric therapy of urinary tract infections.
Abdu, A., & Lamikanra, A. (2016). Linezolid and Methicillin Resistances in S. aureus Isolated from the Anterior Nares of Apparently Healthy Undergraduates of the Niger Delta University, Nigeria. British Microbiology Research Journal, 15(6), 1-10. Crossref |
||||
Aboderin, O. A., Abdu, A., Odetoyinbo, B. W., & Lamikanra, A. (2009). Antimicrobial resistance in Esherichia coli strains from urinary tract infections. Journal of National Medical Association, 101, 1268-73. Crossref |
||||
Abubakar, E. M. (2009). Antimicrobial susceptibility pattern of pathogenic bacteria causing urinary tract infections at the Specialist Hospital, Yola, Adamawa State, Nigeria. Journal of Clinical Medicine Research, 1(1), 001-008. | ||||
Adeyemi, O. A., Gideon, E. E., Eromosele, H. I., Chimerenma, E. A., Oladokun, S. O., Ogochukwu, E. U., Olufunmilayo, R. A., & Favour, E. E. (2014). Antibiotics Susceptibility Patterns of some Uropathogens to Nitrofurantoin and Nalidixic Acid among Pregnant Women with Urinary Tract Infections in Federal Medical Centre, Bida, Niger-State, North Central, Nigeria. American Journal of Epidemiology and Infectious Disease, 2(4), 88-92. Crossref |
||||
Agbagwa, O. E., & Ifeanacho Emeka, J. U. (2015). The Prevalence of UTI Pathogens in Urine Specimen Obtained from a Hospital in Rivers State, Nigeria. Journal of Microbiology Research, 5(5), 143-148. | ||||
Aghazadeh, M., Sari, S., Nahaie, M., Hashemi, R. S. S., & Mehri, S. (2015). Prevalence and Antibiotic Susceptibility Pattern of E. coli Isolated from Urinary Tract Infection in Patients with Renal Failure Disease and Renal Transplant Recipients. Tropical Journal of Pharmaceutical Research, 14 (4), 649-653. Crossref |
||||
Ajide, B., Adogo., L., Saidu, H., & Enna, M. (2016). Prevalence of Urinary Tract Infection among Pregnant Women Receiving Antenatal Care in Two Primary Health Care Centres in Karu Nasarawa State, Nigeria. British Microbiology Research Journal, 12(3), 1-8. Crossref |
||||
Akinyemi, K. O., Alabi, S.A., Taiwo, M. A., & Omonigbehin, E. A. (1997). Antimicrobial susceptibility pattern and plasmid profiles of pathogenic bacteria isolated from subjects with urinary tract infections in Lagos, Nigeria. Nigerian Quarterly Journal of Hospital Medicine, 1, 7–11. | ||||
Akoachere, J.-F. T. K., Yvonne, S., Akum, N. H., & Seraphine, E. N. (2012). Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns. BMC Research Notes, 5(article 219). Crossref |
||||
Akortha, E. E., & Ibadin, O. K. (2008). Incidence and antibiotic susceptibility pattern of Staphylococcus aureus amongst patients with urinary tract infection (UTI) in UBTH Benin City, Nigeria. African Journal of Biotechnology, 7(11),1637–1640. Crossref |
||||
Akram, M., Shahid, M., & Khan, A. U. (2007). Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Annals of clinical microbiology and antimicrobials, 6(1), 4. Crossref |
||||
Al-Jebouri, M. M, & Mdish, A, S. (2013). Antibiotic Resistance Pattern of Bacteria Isolated from Patients of Urinary Tract Infections in Iraq. Open Journal of Urology, 3, 124-131. Crossref |
||||
Al-Jebouri, O. A. H. (2006). The Relationship between Urinary Caliculi Types and Urinary Tract Infections among Patients in Tikrit District, M. Sc. Thesis, University of Tikrit, Tikrit. | ||||
Amin, M., Mehdinejad, M., & Pourdangchi, Z. (2009). Study of bacteria isolated from urinary tract infections and determination of their susceptibility to antibiotics. Jundishapur Journal of Microbiology, 2(3), 118-23. | ||||
Andrade, S. S., Sader, H. S., Jones, R.N., Pereira, A. S., Pignatari, A. C., & Gales, A. C. (2006). Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines? Memórias do Instituto Oswaldo Cruz, 101, 741-8. Crossref |
||||
Annabelle, T., Dytan, M.D., Jennifer, A., & Chua, M. D. (1999). Surveillance of pathogens and resistance patterns in urinary tract infections. Philippine Journal of Microbiology and Infectious Diseases, 28(1), 11-14. | ||||
Arul, K. C., Prakasam, K. G., Kumar, D., & Vijayan, M. (2012). A cross sectional study on distribution of urinary tract infection and their antibiotic utilization pattern in Kerala. International Journal of Research in Pharmaceutical and Biomedical Sciences, 3(3), 1125–1130. | ||||
Bahadin, J., Teo, S. S. H., & Mathew, S. (2011). Aetiology of community-acquired urinary tract infection and antimicrobial susceptibility patterns of uropathogens isolated. Singapore Medical Journal, 52(6), 415-420. | ||||
Bano, K., Khan, J., Rifat, Begum, H., Munir, S., Akbar, N. U., Ansari, J. A., & Anees, M. (2012). Patterns of antibiotic sensitivity of bacterial pathogens among urinary tract infections (UTI) patients in a Pakistani population. African Journal of Microbiology Research, 6, 414-420. | ||||
Bigwan, E. I., & Elijah, D. (2013). Prevalence of Escherichia coli among uropathogens in asymptomatic bacteriuria in a Nigerian Tertiary School in Jos, Nigeria. International Journal of Biomedical and Advance Research, 4(3), 198–202. Crossref |
||||
Butcu, M., Akcay, S. S., Inan, A. S., Aksaray, S., Engin, D. O., & Calisici, G. (2011). In vitro susceptibility of enterococci strains isolated from urine samples to fosfomycin and other antibiotics. Journal of Infection and Chemotherapy, 17, 575–578. Crossref |
||||
Cheesbrough, M. (2006). District Laboratory Practice in Tropical Countries. 2nd Edition, Cambridge University Press. Pp. 64-70. Crossref |
||||
Clinical and Laboratory Standards Institute (CLSI) (2017). Performance Standards for Antimicrobial Susceptibility Testing. Twenty-seventh Information Supplement, 37(1), M100-S26:1-249. | ||||
Collee, J. G., Miles, R. S., & Watt, B. (1996). Tests for the identification of bacteria. in Mackie and Mc Artney Practical Medical Microbiology, J. G. Collee, A. G. Fraser, B. P. Marmion, and A. Simmons, (Eds.), Churchill Livingstone, London, UK. p. 433. | ||||
Coyle, E. A., Kaatz, G. W., & Ryba, M. J. (2001). Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumonia. Antimicrobial Agents and Chemotherapy, 45(6), 1654-1659. Crossref |
||||
Cullen, I. M., Manecksha, R. P., McCullagh, E., Ahmad, S., O'Kelly, F., Flynn, R., McDermott, T. E., Murphy, P., Grainger, R., Fennell, J. P., & Thornhill, J.A. (2013). An 11 year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999–2009. Irish Journal of Medical Science, 182, 81-89. Crossref |
||||
Dada-Adegbola, H., & Muili, K. A. (2010). Antibiotic susceptibility pattern of urinary tract pathogens in Ibadan, Nigeria. African Journal of Medical Research, 39(3), 173-179. | ||||
Das, R. N., Chandrashekhar, T. S., Joshi, H. S., Gurung, M., Shrestha, N., & Shivananda, P. G. (2006). Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal. Singapore Medical Journal, 47(4), 281-285. | ||||
Dash, M., Padhi, S., Mohanty, I., Panda, P., & Parida, B. (2013). Antimicrobial resistance in pathogens causing urinary tract infections in a rural community of Odisha, India. Journal of Family and Community Medicine, 20(1), 20-26. Crossref |
||||
David, C., Bean, D., Krahe, D., & Wareham, W. (2008). Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Annals of Clinical Microbiology and Antimicrobials, 7, 13. Crossref |
||||
Daza, R., Gutierrez, J., & Piedrola, G. (2001). Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. International Journal of Antimicrobial Agents, 18, 211-215. Crossref |
||||
Derbie, A., Hailu, D., Mekonnen, D., Abera, B., & Yitayew, G. (2017). Antibiogram profile of uropathogens isolated at Bahir Dar Regional Health Research Laboratory Centre, Northwest Ethiopia. Pan African Medical Journal, 26, 134. Crossref |
||||
Drago, L., De Vecchi, E., Mombelli, B., Nicola, L., Valli, M., & Gismondo, M. R. (2001). Activity of levofloxacin and ciprofloxacin against urinary pathogens. Journal of Antimicrobial Chemotherapy, 48(1), 37-45. Crossref |
||||
Ebie, M. Y., Kandaki-Olukemi, Y. T., Ayanbadejo, J., & Tanyigna, K. B. (2001). UTI infections in a Nigerian Military Hospital. Nigerian Journal of Microbiology, 15(1), 31-37. | ||||
Ebrahimzadeh, M. A., Mahdavee, M. R., & Vahedi, M. 92005). Antibiotic resistance in E. coli isolated from urine: A2-years study isolated from patient with urinary tract infections in Iran. Journal of Cell and Tissue Research, 5(2), 445-448. | ||||
Ehinmidu, J. O. (2003). Antibiotic susceptibility patterns of urine bacterial isolates in Zaria, Nigeria. Tropical Journal of Pharmaceutical Research, 2(2), 223-228. | ||||
Ekweozor, C. C., & Onyemenen, T. N. (1996). Urinary Tract Infection in Ibadan, Nigeria: causative organism and anti-microbial sensitivity pattern, African Journal of Medical Sciences, 25, 165-69. | ||||
Foxman, B. (2010). The epidemiology of urinary tract infection. Nature Reviews Urology, 7(12), 653-660. Crossref |
||||
Foxman, B., & Brown, P. (2003). Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infectious Disease Clinics of North America, 17(2), 227-241. Crossref |
||||
Foxman, B., Barlow, R.., D'Arcy, H., Gillespie, B., & Sobel, J. D. (2000). Urinary tract infection: self-reported incidence and associated costs. Annals of Epidemiology, 10(8), 509-515. Crossref |
||||
Gales, C. A., Jones, R. N., Gordon, K. A., Sader, S. H., Wilke, W. W., Beach, M. L., Pfaller, M. A., & Doern, G. V. (2000). SENTRY Study Group Latin America. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infections pathogens in hospitalized patients in Latin America: Report from the second year of the SENTRY Antimicrobial Surveillance Programme (1998). Journal of Antimicrobial Chemotherapy, 45, 295-303. Crossref |
||||
Garc’ıa-Mor’ua, A., Hern’andez-Torres, A., Salazar-de-Hoyos, J. L., Jaime-D’avila, R., & G’omez-Guerra, L. S. (2009). Community acquired urinary tract infection etiology and antibiotic resistance in a Mexican population group. Revista Mexicana de Urolog’ıa, 69, 45-48. | ||||
Goettsch, W., van Pelt, W., Nagelkerke, N., Hendrix, M. G., Buiting, A. G., Petit, P. L., Sabbe, L. J., van Griethuvsen, A. J., & Neelinga, A. J. (2000). Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. Journal of Antimicrobial Chemotherapy, 46, 223-228. Crossref |
||||
Goldstein, F. W. (2000). Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre study group. European Journal of Clinical Microbiology and Infectious Diseases, 19, 112-117. Crossref |
||||
Gonzalez, C. M., & Schaeffer, A. J. (1999). Treatment of urinary tract infection: what's old, what's new, and what works. World Journal of Urology, 17(6), 372–382. Crossref |
||||
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005). Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. The Lancet, 365(9459), 579-587. Crossref |
||||
Grude, N., Tveten, Y., & Kristiansen, B. E. (2001). Urinary tract infections in Norway, bacterial etiology and susceptibility: A retrospective study of clinical isolates. Clinical Microbiology and Infection, 7, 543-547. Crossref |
||||
Gundogdu, A., Long, Y. B., Vollmerhausen, T. L., & Katouli, M. (2011). Antimicrobial resistance and distribution of sul genes and integron-associated intI genes among uropathogenic Escherichia coli in Queensland, Australia. Journal of Medical Microbiology, 60, 1633–1642. Crossref |
||||
Gupta, K. (2003). Emerging antibiotic resistance in urinary tract pathogens. Infectious Disease Clinics of North America, 17, 321–323. Crossref |
||||
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., & Soper, D. E. (2011). International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases, 52(5), e103-120. Crossref |
||||
Gupta, K., Scholes, D., & Stamm, W. E. (1999). Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. Journal of the American Medical Association, 281(8), 736-738. Crossref |
||||
Ho, P. L., Wong, R. C., Yip, K. S., Loke, S. L., Leung, M. S., Mak, G. C., Chow, F. K., Tsang, K. W., & Que, T. L. (2007). Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women, emerging multidrug resistance phenotypes. Diagnostic Microbiology and Infectious Disease, 59, 439-445. Crossref |
||||
Hoban, D. J., Lascols, C., Nicolle, L. E., Badal, R., Bouchillon, S., Hackel, M., & Hawser, S. (2012). Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe, results from the SMART study 2009–2010. Diagnostic Microbiology and Infectious Disease, 74, 62-67. Crossref |
||||
Hryniewcz, K., Szczypa, K., Sulikowska, A., Jankowski, K., Betlejewska, K., & Hryniewcz, W. (2001). Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. Journal of Antimicrobial Chemotherapy, 47(6), 773-80. Crossref |
||||
Huttner, A., Verhaegh, M. E., Harbarth, S., Muller, E. A., Theuretzbacher, U., & Mouton, W. J. (2015). Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. Journal of Antimicrobial Chemotherapy, 70, 2456-2464. Crossref |
||||
Ibeneme, C. A., Oguonu, T., Okafor, H. U., Ikefuna, A. N., & Ozumba, U. C. (2014). Urinary tract infection in febrile under five children in Enugu, South Eastern Nigeria. Nigerian Journal of Clinical Practice, 17, 624-628. Crossref |
||||
Igwegbe, A. O., Ugboaja, J. O., & Okoli, O. A., (2012). Prevalence of asymptomatic bacteriuria among pregnant women in Nnewi, southeast Nigeria. International Journal of Biological and Chemical Sciences, 6 (1), 88-98. Crossref |
||||
Jeevan, S., & Zarrin, A. (2017). Detection of Methicillin Resistant, ESBL and Amp C Producing Uropathogens from a Tertiary Care Hospital in North India. International Journal of Current Microbiology and Applied Sciences, 6(7), 770-778. Crossref |
||||
Jones, M. E., Visser, M. R., Klootwijk, M., Heisig, P., Verhoef, J., & Schmitz, F.-J. (1999). Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin- dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains. Antimicrobial Agents and Chemotherapy, 43(2), 421-423. |
Kahlmeter G. (2000). The ECO. SENS Project, a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens–interim report. Journal of Antimicrobial and Chemotherapy, 46(Suppl. 1), 15-22. Crossref |
||||
Kahlmeter, G. (2003). An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS project. Journal of Antimicrobial Chemotherapy, 51(1), 69-76. Crossref |
||||
Kalantar, E., Farhadifar, F., & Nikkho, B. (2008). Asymptomatic Bacteriuria among Pregnant Women Referred to Outpatient Clinics in Sanandaj, Iran. International Brazilian Journal of Urology, 34 (6), 699-707. Crossref |
||||
Killgore, K. M., March, K. L., & Guglielmo, B. J. (2004). Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Annals of Pharmacotherapy, 38, 1148-52. Crossref |
||||
Kolawole, A. S., Kolawole, O. M., Kandaki-Olukemi, Y. T., Babatunde, S. K., Durowade, K. A., & Kolawole, C. F. (2009). Prevalence of urinary tract infections (UTI) among patients attending Dalhatu Araf Specialist Hospital, Lafia, Nasarawa State, Nigeria. International Journal of Medicinal Medical Sciences, 1(5), 163–167. | ||||
Kothari, A., & Sagar, V. (2008). Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. The Journal of Infection in Developing Countries, 2(5), 354-358. Crossref |
||||
Krumperman, H. P. (1983). Multiple Antibiotic Resistance Indexing of Escherichia coli to Identify High-Risk Sources of Fecal Contamination of Foods. Applied and Environmental Microbiology, 46(1), 165-170. | ||||
Lobel, B., Valot, A., Cattoir, V., Lemenand, O., & Gaillot, O. (2008). Comparison of antimicrobial susceptibility of 1,217 Escherichia coli isolates from women with hospital and community-acquired urinary tract infections. Presse Médicale, 37, 746-750. Crossref |
||||
Lucas, M. J., & Cunningham, F. G. (1993). Urinary infection in pregnancy. Clinical Obstetrics and Gynecology, 36(4), 855-868. Crossref |
||||
Maraki, S., Samonis, G., Rafailidis, P. I., Vouloumanou, E. K., Mavromanolakis, E., & Falagas, M. E. (2009). Susceptibility of urinary tract bacteria to fosfomycin. Antimicrobial Agents and Chemotherapy, 53, 4508-4510. Crossref |
||||
Mavroidi, A., Miriagou, V., Liakopoulos, A., Tzelepi, E., Stefos, A., Dalekos, G. N., & Petinaki, E. (2012). Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification. BMC Infectious Diseases, 12, 371. Crossref |
||||
McEwen, L. N., Farjo, R., & Foxman, B. (2003). Antibiotic prescribing for cystitis: how well does it match published guidelines? Annals of Epidemiology, 13(6), 479-483. Crossref |
||||
Mehta, M., Bhardwaj, S., & Sharma, J. (2013). Screening of urinary isolates for the prevalence and antimicrobial susceptibility of Enterobacteria other than Escherichia coli. International Journal of Life Science and Pharma Research, 3(1), 100-104. | ||||
Nzalie, R. N., Gonsu, K. H. & Koulla-Shiro, S. (2016). Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City. International Journal of Microbiology, 2016, Article ID 3240268. Crossref |
||||
Ochada, N. S., Nasiru, I. A., Thairu, Y., Okanlowan, M. B., & Abdulakeem, Y. O. (2014). Antimicrobial Susceptibility pattern of urinary pathogens isolated from two Tertiary Hospitals in southwestern Nigeria. African Journal of Clinical and Experimental Microbiology, 16(1), 12-22. Crossref |
||||
Ojo, D. N., Osuolale, K.O., & Mafiana, C.P. (2004). Prevalence of Urinary Tract Infection among Students in a Nigerian University. Proceedings of the International Conference on Science and National Development, 25th -28th October, 2014. Pp. 120-123. | ||||
Okonko I. O., Donbraye-Emmanuel, O. B., Ijandipe, L. A., Ogun, A. A., Adedeji, A. O., & Udeze, A. O. (2009a). Antibiotics sensitivity and resistance patterns of uropathogens to Nitrofurantoin and Nalidixic acid in pregnant women with urinary tract infections in Ibadan, Nigeria. Middle East Journal of Scientific Research, 4 (2), 105-109. | ||||
Okonko, I. O., Ijandipe, L. A., Ilusanya, O. A., Donbraye-Emmanuel, O. B., Ejembi, J., Udeze, A. O., Egun O. C., Fowotade, A., & Nkang, A. O. (2009b). Incidence of urinary tract infection (UTI) among pregnant women in Ibadan, South-Western Nigeria. African Journal of Biotechnology, 8(23), 6649-6657. | ||||
Okonko, I. O., Soleye, F. A., Amusan, T. A., Ogun, A. A., Ogunnusi, T. A., & Ejembi, J. (2009c). Incidence of multi-drug resistance (MDR) organisms in Abeokuta, Southwestern Nigeria. Global Journal of Pharmacy & Pharmaceutical Sciences, 3(2), 69-80. | ||||
Onoh, R. C., Umeora, O. U. J., Egwuatu, V. E., Ezeonu, P. O., & Onoh, T. J. P. (2013). Antibiotics sensitivity pattern of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria. Journal of Infection and Drug Resistance, 6, 225-233. Crossref |
||||
Oreh, N. C., & Attama A. A (2013). Comparison of susceptibility patterns of Escherichia coli isolated from urinary tract infections in two health institutions in South-South Nigeria to commonly used antimicrobials. African Journal of Microbiology Research, 7(24), 3066-3070. Crossref |
||||
Orrett, F. A. (2001). Urinary tract infections in general practice in a rural community in South Trinidad. Saudi Medical Journal, 22(6), 537-540. | ||||
Peixoto De Miranda, E. J., Salvador De Oliveira, G. S., Roque, F. L., Dos Santos, S. R., Olmos, R. D., & Lotufo, P. A. (2014). Susceptibility to antibiotics in urinary tract infections in a secondary care setting from 2005-2006 and 2010-2011, in São Paulo, Brazil: data from 11,943 urine cultures. The Revista do Instituto de Medicina Tropical de São Paulo, 56(4): 313-24. Crossref |
||||
Prakash, D., & Saxena, R. S. (2013). Distribution and Antimicrobial Susceptibility Pattern of Bacterial Pathogens Causing Urinary Tract Infection in Urban Community of Meerut City, India. International Scholarly Research Notices: Microbiology – Hindawi 2013:749629. | ||||
Rangari, A. A., Sharma, S., Tyagi, N., Paramjit Singh, P., Singh, G., & Rameshwari Thakur, R. (2015). Antibiotic Susceptibility Pattern of Bacterial Uropathogens Isolated from Patients at a Tertiary Care Hospital in Western Uttar Pradesh of India. International Journal of Current Microbiology and Applied Sciences, 4(10), 646-657. | ||||
Rego, L. L., Glazer, S. C., & Zimmern, E. P. (2016). Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient. Urological Science, 27, 193 -198. Crossref |
||||
Rocha, J. L., Tuon, F. F., & Johnson, J. R. (2012). Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance. Brazilian Journal of Infectious Diseases, 16, 115-121. Crossref |
||||
Sabir, S., Anjum, A. A., Ijaz, T., Ali, M. A., Khan, M. R., & Nawaz, M. (2014). Isolation and antibiotic susceptibility of E. coli from urinary tract infections in a tertiary care hospital. Pakistan Journal of Medical Science, 30(2), 389-392. | ||||
Sabra, S. M., & Abdel-Fattah, M. M. (2012). Epidemiological and microbiological profile of nosocomial infection in Taif hospitals, KSA (2010-2011). World Journal of Medical Sciences, 7(1), 1-9. | ||||
Salas, D. (2011). Antibiotic Sensitivity Pattern of Urinary Tract Infections in a Regional Hospital, Koforidua, Ghana. Tephinet, 17, 19. | ||||
Schaeffer, A. J., Rajan, N., Cao, Q., Anderson, B. E., Pruden, D. L., Sensibar, J., & Duncan, J. L. (2001). Host pathogenesis in urinary tract infections. International Journal of Antimicrobial Agents, 17(4), 245-251. Crossref |
||||
Schmiemann, G., Gagyor, I., Hummers-Pradier, E., & Bleidorn, J. (2012). Resistance profiles of urinary tract infections in general practice–an observational study. BMC Urology, 12, 33. Crossref |
||||
Selvakumar, B. N., & Jasmine, R. (2007). Antibiotic susceptibility of ESBL-producing urinary isolates at a Tertiary Care Hospital in Tiruchirappalli South India. Journal of Medical Sciences, 7(3), 443-446. Crossref |
||||
Sevki, C., Ayla, S. O.¸ Rana, K., Sibel, S., Serpil, U., Belgin, P., & Nuri, D. (2011). Asymptomatic Bacteriuria and Antibacterial Susceptibility Pattern in an Obstetric Population. ISRN Obstetrics and Gynecology, 2011, Article ID 721872, 4 pages. | ||||
Shaifali, I., Gupta, U., Mahmood, S. E., & Ahmed, J. (2012). Antibiotic susceptibility patterns of urinary pathogens in female outpatients. North American Journal of Medical Sciences, 4, 163-169. Crossref |
||||
Smelov, V., Naber, K., & Bjerklund- Johansen, E. T. (2016). Improved Classification of Urinary Tract Infection: Future Considerations. European Urology Supplements, 15(4), 71-80. Crossref |
||||
Sobel, J. D., & D. Kaye, D. (2010). Urinary tract infections, G. L. Mandell, J. E. Bennett, and R. Dolin. In Mandell, Douglas and Bennett's (Eds.), Principles and Practice of Infectious Diseases, Churchill Livingstone, Philadelphia, Pa, USA, 7th edition. Pp. 957–985. Crossref |
||||
Swartz, M. N. (1997). Use of antimicrobial agents and drug resistance. New England Journal of Medicine, 337, 491-92. Crossref |
||||
Tambekar, D. H., Dhanorkar, D. V., Gulhane, S. R., Khandelwal, V. K., & Dudhane, M. N., (2006). Antibacterial susceptibility of some urinary tract pathogens to commonly used antibiotics. African Journal of Biotechnology, 5(17), 1562-1565. | ||||
Tansarli, S. G., Athanasiou, S., & Falagasa, E. M. (2013). Evaluation of Antimicrobial Susceptibility of Enterobacteriaceae Causing Urinary Tract Infections in Africa. Antimicrobial Agents and Chemotherapy, 57(8), 3628–3639. Crossref |
||||
Uddin, M. N., & Khan, T. (2016). Prevalence of Urinary Tract Infection among Pregnant Women at Ibrahim Iqbal Memorial Hospital, Chandanaish, Bangladesh. American Journal of Clinical Medicine Research, 4(3), 47-51. | ||||
Uwaezuoke, J. C., & Ogbulie, J. N. (2006). Antibiotic Sensitivity Pattern of Urinary Tract Pathogens in Port – Harcourt, Nigeria. Journal of Applied Science & Environmental Management, 10 (3) 103-107. Crossref |
||||
Warren, J. W., Abrutyn, E., Richard Hebel, J., Johnson, J. R., Schaeffer, A. J., & Stamm, W. E. (1999). Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clinical Infectious Diseases, 29 (4), 745–758. Crossref |
||||
Warren, J. W., Tenney, J. H., & Hoopes, J. M. (1982). A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. Journal of Infectious Diseases, 146(6), 719-723. Crossref |
||||
Yengkokpam, C., Ingudam, D., Yengkokpam, I.S., & Jha, B. K. (2007). Antibiotic susceptibility pattern of urinary isolates in Imphal (Manipur) India. Nepal Medical College Journal, 9, 170-172. | ||||
Zelikovic, I., Adelman, R. D., & Nancarrow, P. A. (1992). Urinary tract infections in children—an update. Western Journal of Medicine, 157(5), 554–561. | ||||
Zhao, L., Chen, X., Zhu, X., Yang, W., Dong, L., Xu, X., Gao, S., & Liu X. (2009). Prevalence of virulence factors and antimicrobial resistance of uropathogenic Escherichia coli in Jiangsu province (China). Urology, 74, 702-707. Crossref |